A retrospective study on the prevalence of hepatitis E virus (HEV) infectio
n was conducted in selected populations in Rio de Janeiro, Brazil. A total
of 1,115 subjects were tested including 146 patients with acute Non-A Non-B
Non-C (NANBNC) viral hepatitis. 65 hemodialysis patients, 93 blood donors,
102 intravenous drug users (IVDUs), 304 pregnant women, 145 individuals li
ving in the rural area and 260 individuals living in the urban area. In ord
er to characterize a favorable epidemiological set for enterically transmit
ted infection in the studied populations we also evaluated the prevalence o
f anti-HAV IgG (hepatitis A virus) antibodies. Specific antibodies to HEV (
anti-HEV IgG) were detected by a commercial EIA and specific antibodies to
HAV (anti-HAV IgG) were detected by a commercial EIA and specific antibodie
s to HAV (anti-HAV IgG) were detected using a competitive "in house" EIA. W
e found a high prevalence of anti-HAV IgG in these populations, that could
indicate some risk for infections transmitted via the fecal-oral route. The
anti-HEV IgG prevalence among the different groups were: 2.1% in patients
with acute NANBNC viral hepatitis, 6.2% in hemodialysis patients, 4.3% in b
lood donors, 11.8% in IVDUs, 1% in pregnant women, and 2.1% in individuals
form the rural area. Among individuals living in the urban area we did not
find a single positive serum sample. Our results demonstrated the presence
of anti-HEV IgG in almost all studied populations; however, further studies
are necessary to establish the real situation of HEV epidemiology in Rio d
e Janeiro, Brazil.